Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) EBITDA Margin % : -195.62% (As of Nov. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Cannabis Bioscience International Holdings's EBITDA for the six months ended in Nov. 2023 was $-0.27 Mil. Cannabis Bioscience International Holdings's Revenue for the six months ended in Nov. 2023 was $0.14 Mil. Therefore, Cannabis Bioscience International Holdings's EBITDA margin for the quarter that ended in Nov. 2023 was -195.62%.

Cannabis Bioscience International Holdings EBITDA Margin % Historical Data

The historical data trend for Cannabis Bioscience International Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Bioscience International Holdings EBITDA Margin % Chart

Cannabis Bioscience International Holdings Annual Data

Trend

Dec06

Dec07

May09

May10

May11

EBITDA Margin %

-105.56

17.62

-15.20

19.42

Cannabis Bioscience International Holdings Semi-Annual Data
	Dec06	Jun07	Dec07	Jun08	May09	Nov09	May10	Nov10	May11	Nov11	Nov22	Nov23
EBITDA Margin %	Get a 7-Day Free Trial							23.24	14.48	25.58	-174.43	-195.62

Competitive Comparison of Cannabis Bioscience International Holdings's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannabis Bioscience International Holdings's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Bioscience International Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Cannabis Bioscience International Holdings's EBITDA Margin % falls into.

Cannabis Bioscience International Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Cannabis Bioscience International Holdings's EBITDA Margin % for the fiscal year that ended in May. 2011 is calculated as

EBITDA Margin %	=	EBITDA (A: May. 2011 )	/	Revenue (A: May. 2011 )
	=	16.211	/	83.461
	=	19.42 %

Cannabis Bioscience International Holdings's EBITDA Margin % for the quarter that ended in Nov. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Nov. 2023 )	/	Revenue (Q: Nov. 2023 )
	=	-0.268	/	0.137
	=	-195.62 %

Cannabis Bioscience International Holdings (OTCPK:CBIH) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Cannabis Bioscience International Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

6201 Bonhomme Road, Suite 466S, Houston, TX, USA, 77036

Website

https://www.cbih.net

Cannabis Bioscience International Holdings Inc is engaged in providing educational systems relating to cannabis and services in therapeutic areas. of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. The Company generates revenue from multiple streams, namely, clinical trials, consulting fees, video courses, seminars, royalties, and merchandise sales. The company generates the majority of its revenue from clinical trials.